CT1190B
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CT1190B, covering 2025-01-03 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) [Phase 1]